Bio 54, LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B (NCT06205615) | Bio 54, LLC | 2024-01-24 |
| Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154 (NCT05837338) | Bio 54, LLC | 2023-05-01 |
Track Bio 54, LLC automatically
Every clearance here is in the API, with alerts when new ones post.